Tatva Chintan Pharma Chem IPO gets a subscribe rating from Anand Rathi, which is positive on the company#39;s long-term prospects Post navigation Zomato will be a long-term compounding story instead of multibagger one: Vinit Bolinjkar of Ventura Securities Crypto world faces a fateful choice